Chenlv Herb
1. Executive Summary & Scientific Background
Cholic acid and its derivative salts are steroid acids found predominantly in the bile of mammals. Chemically classified as 3α,7α,12α-trihydroxy-5β-cholan-24-oic acid, cholic acid serves as a fundamental building block in both physiological biochemistry and pharmacological science. Over the past two decades, the cholic acid series has transitioned from a basic physiological surfactant to a highly sought-after raw material for the synthesis of advanced therapeutics, including **Ursodeoxycholic Acid (UDCA)**, **Obeticholic Acid (OCA)**, and various targeted drug delivery systems.
As a premier global manufacturer, we deliver clinical-grade, high-purity cholic acid series compounds optimized for the rigorous requirements of research institutions, diagnostic developers, and commercial pharmaceutical manufacturers worldwide. By offering an uninterrupted supply chain directly from our production site to key biotech hubs like Toronto, Ontario, we ensure that the local biotechnology cluster maintains its competitive edge through premium chemical purity, reliable delivery, and robust documentation.
2. Toronto's Life Sciences Cluster & Industrial Raw Material Demands
The Greater Toronto Area (GTA) and the broader Southern Ontario biotechnology corridor constitute one of North America's largest life science clusters. With major research epicenters such as the MaRS Discovery District, the University of Toronto, and local commercial manufacturing hubs in Mississauga and Oakville, the regional demand for high-purity biochemical reagents has grown exponentially.
Our cholic acid series products cater directly to these localized industrial requirements:
- Diagnostic Reagent Manufacturing: Local clinical diagnostic firms utilize Cholic Acid, Bilirubin, and Cholesterol as benchmark calibration controls and substrate elements in enzymatic assays for liver panel tests.
- Advanced Drug Delivery Systems (Liposomal Formulations): Researchers in Toronto’s nanomedicine labs rely on high-purity Cholesterol and sodium deoxycholate to construct stable liposomes, particularly for mRNA vaccine delivery platforms and targeted oncology therapeutics.
- Contract Research Organizations (CROs): Pre-clinical toxicological profiling and metabolic research in Ontario require highly pure, trace-metal-free bile acid derivatives to simulate enterohepatic circulation and study FXR/TGR5 receptor pathways.
3. The Competitive Edge: China Supply Chain Integration & Manufacturing Excellence
Leveraging our state-of-the-art facility operated by Chengdu Chenlv Herb Co., Ltd., we bridge the gap between heavy chemical extraction capacity and cleanroom-refined API production. Established in 2012, our high-tech enterprise integrates advanced natural product extraction, chemical synthesis, and international quality management frameworks.
Our factory in Chengdu spans over 9,514 square meters and features dedicated cleanrooms, crystallization suites, and analytical testing laboratories equipped with HPLC, GC, LC-MS, and ICP-MS systems. This direct manufacturer advantage allows us to offer:
- Uncompromised Quality Control: Consistent batch-to-batch reproducibility with purities exceeding 98% to 99% by HPLC.
- Global Regulatory Alignment: Supporting clients with comprehensive technical packages, including DMFs, BSE/TSE-free declarations, and Kosher/Halal certifications.
- Cost Efficiency: Eliminating intermediaries to provide competitive direct factory quotes, allowing Toronto-based labs and plants to optimize their R&D budgets.
4. Localized Support & Compliance Safeguards for Canadian Procurement
Importing raw pharmaceutical ingredients into Canada requires strict adherence to Health Canada guidelines, particularly for materials derived from natural or animal sources. To facilitate seamless clearance through the Port of Toronto and Pearson International Airport (YYZ), we provide:
Our dedicated export compliance team is fully versed in the Canadian Food and Drugs Act. Every shipment is backed by a comprehensive documentation portfolio, including Certificates of Analysis (COA) containing assay specifications, heavy metal limits, residual solvent profiles (in line with ICH Q3C), and microbial limit testing. By prioritizing transparency and traceability, we alleviate the regulatory hurdles associated with international biochemical sourcing.
